← back to search

Michael P. Thirlwell

McGill University Health Centre · CA
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology, and HER2/EGFR in Cancer Research.
h-index
25
citations
2,180
works
67
NIH funding
primary concept
Medicine
email

Recent publications

Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP)
Journal of Clinical Oncology 2024cited by 31position: middledoi
Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases
JAMA Oncology 2022cited by 23position: middledoi
Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial
Annals of Oncology 2020cited by 105position: middledoi
Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor–Positive Early Breast Cancer: PALLET Trial
Journal of Clinical Oncology 2018cited by 233position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

No co-authors indexed yet.